Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$17.18 - $22.6 $262,699 - $345,576
-15,291 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$11.5 - $17.96 $175,846 - $274,626
15,291 New
15,291 $274,000
Q3 2020

Nov 16, 2020

SELL
$10.62 - $13.12 $5,363 - $6,625
-505 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$7.35 - $10.81 $2,690 - $3,956
366 Added 263.31%
505 $5,000
Q1 2020

May 15, 2020

BUY
$8.38 - $17.34 $1,164 - $2,410
139 New
139 $1,000
Q4 2019

Feb 14, 2020

SELL
$11.18 - $18.6 $141,885 - $236,052
-12,691 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$12.09 - $20.46 $153,434 - $259,657
12,691 New
12,691 $158,000
Q1 2019

May 15, 2019

SELL
$14.62 - $22.13 $160,820 - $243,430
-11,000 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$17.09 - $38.25 $187,990 - $420,750
11,000 New
11,000 $225,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $749M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.